What is Movano Health?

Movano Health: ring sub-cohort entity within biometric cluster

Movano Health is the operating company behind the Evie Ring, a smart ring biometric positioned within the biometric cluster's ring sub-cohort alongside Oura + Whoop + RingConn + Ultrahuman + Happy Ring. Per consumer surface, Evie Ring operates at consumer retail pricing tier.

The verified entity scope per registry state: Movano Health is the canonical operating company entity; Evie Ring is the consumer-shipped product. The remainder of the editorial scope at this entity carries an active cap-flag for the corporate-state-shift framework that the registry references but verification at primary-source depth has not landed.

---

CRITICAL CORPORATE-STATE-SHIFT CAP-FLAG: reverse merger via Corvex

Per registry-surface references on the Movano Health entity page, Movano operates within a corporate-state-shift via reverse merger structure. The registry surfaces "Corvex" and "reverse merger" as part of the Movano corporate-state framing. Per cap-flag-as-trust-signal, the reverse-merger structure is verified at the registry-framing level; specific mechanics + timing + post-merger corporate scope operate at lower verification posture pending primary-source confirmation:

• Reverse-merger structure verified per registry framing: Movano Health corporate-state operates within a reverse-merger structure involving Corvex. The registry-surface reference is the load-bearing primary-source-anchored verification at this depth.
• Specific reverse-merger mechanics cap-flagged: typical reverse-merger structures involve a public shell entity merging with a private operating company. Specific transaction structure (public-shell-becomes-private vs private-becomes-public vs name-change-mechanics) operates at lower verification posture pending SEC primary-source confirmation (8-K + S-1 + proxy statements).
• Specific timing cap-flagged: trade-press coverage references late-2025/early-2026 timing for the reverse-merger close; specific close date + filing dates operate at lower verification posture pending SEC primary-source confirmation.
• Post-merger corporate scope cap-flagged: post-merger entity scope (which corporate entity continues + which dissolves + how the ticker symbol + which company name surfaces commercially + how product-line continuity operates) all cap-flagged at honest-not-known depth pending primary-source verification.

Per DEPLOY's framework, the corporate-state-shift framing matters editorially at the lifecycle-flip layer. Trade-press coverage of biometric ring sub-cohort entries doesn't typically surface reverse-merger structures with verification depth; the framework reads the corporate-state-shift state as editorial signal at the entity-verification layer.

---

The lifecycle-flip editorial framing

The reverse-merger structure surfaces a structurally distinct editorial position from the broader biometric ring sub-cohort. Other ring sub-cohort entities operate clean corporate-state positions per existing entity anchor framings:

• Oura Ring: independent venture; '178 patent holder + plaintiff in ITC dispute; established Finnish corporate-state continuity.
• RingConn (Gen 2 / Gen 3): independent venture; settled-licensed cleanly with Oura on '178 patent.
• Ultrahuman Ring (Air / Pro): independent venture; US market access blocked October 21, 2025 → restored March 24, 2026 via Ring Pro unibody redesign.
• Happy Ring: independent venture; Happy Health corporate-state continuing; $60M Series A August 2022; commercially active across 48 states.
• Whoop: independent venture; $10.1B Series G March 2026 lead Collaborative Fund.

Movano Health operates at structurally distinct corporate-state position within the ring sub-cohort: a reverse-merger structure surfaces lifecycle-flip dynamics that aren't present in the independent-venture cohort entries. The lifecycle-flip framing is editorially distinctive verification-posture work per cap-flag-as-trust-signal: the framework reads corporate-state-shift states honestly with the verification depth surfaced explicitly.

Per DEPLOY's how-deploy-verifies methodology editorial, the reverse-merger framing surfaces multiple primary-source verification dependencies at once. The transaction structure operates at SEC primary-source verification posture. The product-line continuity operates at company primary-source verification posture. The post-merger commercial trajectory operates at trade-press observational depth pending primary-source confirmation.

---

Evie Ring: consumer ring product scope

Per registry verification, Evie Ring is the consumer-shipped Movano Health product. The Evie Ring operates at consumer retail pricing tier per the consumer surface. Per cap-flag-as-trust-signal, specific product feature claims + FDA clearance posture + commercial deployment scope + AI-substance tier all operate at lower verification posture pending primary-source confirmation:

• Product positioning verified: smart ring biometric within the consumer ring sub-cohort.
• Product positioning cap-flagged: specific feature claims (heart rate + sleep tracking + temperature + period tracking + AI insights) at primary-source depth pending Movano company communications + product documentation verification.
• FDA clearance posture cap-flagged: specific 510(k) or other FDA clearance scope for any health-claim features at primary-source verification depth pending FDA database confirmation.
• Commercial deployment scope cap-flagged: specific commercial deployment scale + customer count + retail channel coverage at primary-source verification depth pending company communications.
• AI-substance tier cap-flagged: specific AI integration (generative vs adaptive-algorithmic vs rule-based) at primary-source verification depth.

The cap-flag pattern operates per DEPLOY's framework. The verified entity scope (Movano Health company + Evie Ring product registered at registry surface) is load-bearing; specific feature + clearance + deployment + AI claims operate at lower verification posture pending primary-source confirmation. The framework reads what's verified at the depth where it's verified.

---

Cohort positioning: ring sub-cohort entry

Per the biometric cluster framework, Movano Health Evie Ring anchors:

• Ring sub-cohort entry: alongside Oura + Whoop + RingConn + Ultrahuman + Happy Ring; verified entity at the cluster-framework level.
• Reverse-merger corporate-state framing: structurally distinct from independent-venture corporate states across the ring sub-cohort; reverse-merger structure surfaces lifecycle-flip dynamics.
• Verified retail product: Evie Ring consumer-shipped at retail pricing tier per consumer surface.
• Cap-flagged claim depth: specific feature + clearance + deployment + AI-substance claims operate at lower verification posture pending primary-source confirmation.

Contrast within ring sub-cohort:

• RingConn (Gen 2 / Gen 3): $279 subscription-free; AHI 90.7%-claimed but NOT FDA-cleared; ITC settled-licensed (NOT banned per Agent A correction).
• Ultrahuman Ring (Air / Pro): ~$349 hardware + subscription-augmented; AFib via FibriCheck third-party (NOT native cleared); US market access blocked Oct 21 2025 → restored Mar 24 2026.
• Happy Ring: service-gated (NO retail price; insurer-billed Happy Sleep); dual FDA 510(k) clearances K240236 + K242224.
• Oura Ring: hardware purchase + $5.99/mo membership; '178 patent holder.
• Whoop (band cohort exemplar adjacent to ring sub-cohort): subscription-only $239/yr + $239 hardware = ~$478 Year 1.
• Movano Health Evie Ring: reverse-merger corporate-state; retail-positioned consumer ring; specific claim depth cap-flagged.

Consumer pricing surface for Movano Evie Ring is LIVE at deploy.report/price/movano-evie-ring. Registry institutional depth at Movano Health registry company + Evie Ring registry model.

For the canonical biometric cluster context, see the biometric cluster. For the ring sub-cohort verified-vs-claimed framework worked examples, see what is RingConn (AHI-claimed-not-cleared) + what is Happy Ring (dual FDA clearances). For the methodology editorial canonical reference where the cap-flag discipline operates, see how DEPLOY verifies. For the canonical category umbrella, see what is physical AI. For methodology canonical references applicable to Movano Health: verified-vs-claimed at within-entity granularity (within-Movano reverse-merger corporate-state + Evie Ring feature claims + FDA clearance posture cap-flag depth) + the 9-tier source-quality rubric (SEC reverse-merger + Corvex primary-source classification).